- Novo Nordisk stock draws mixed views post guidance cut (NVO) Seeking Alpha
- Wegovy maker Novo’s profit warning triggers $70 billion share rout Reuters
- NVO Stock Crashes 22% After 2025 View Cut: More Downside Ahead? Yahoo Finance
- Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning The New York Times
- Novo CEO’s First Test Is Winning Back the US Weight-Loss Market Bloomberg
Source link
